It works by helping the body regulate blood sugar, slowing digestion, and improving insulin response
Experimental studies have explored its effects in models involving soft tissue injury, gastrointestinal function, vascular biology, and musculoskeletal recovery
Similarly, the estimated treatment difference in STEP 1 was 12.4% compared with 19.1% in BARI-STEP, which was designed based on the STEP 1 trial
The specific reactions users report most often: Compare this to actual GLP-1 receptor agonists, where nausea affects 20 to 44% of users, vomiting 5 to 24%, and constipation 12 to 24% across the STEP 1 and SURMOUNT-1 trial programs
This infusion is often chosen to help support healthy-looking skin and general immune wellness
If it persists, a pharmacist can advise on suitable over-the-counter options